1. Home
  2. Analysis
  3. Neurontin
  4. Atrioventricular-block-complete

Neurontin and Atrioventricular block complete - a phase IV clinical study of FDA data

Summary:

Atrioventricular block complete is reported as a side effect among people who take Neurontin (gabapentin), especially for people who are male, 60+ old, have been taking the drug for 2 - 5 years also take Plavix, and have Atrial fibrillation/flutter.

The phase IV clinical study analyzes which people have Atrioventricular block complete when taking Neurontin. It is created by eHealthMe based on reports of 103,969 people who have side effects when taking Neurontin from the FDA, and is updated regularly.

What is Neurontin?

Neurontin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 107,468 Neurontin users. Check the latest studies of Neurontin.

What is Atrioventricular block complete?

Atrioventricular block complete (heart block complete) is found to be associated with 669 drugs and 951 conditions by eHealthMe. Check the latest studies of Atrioventricular block complete.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

103,969 people reported to have side effects when taking Neurontin.
Among them, 22 people (0.02%) have Atrioventricular block complete.

Could Neurontin cause Atrioventricular block complete?

Among these 22 people:

How long have people been on Neurontin when they have Atrioventricular block complete? *

  • < 1 month: 33.33 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 66.67 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Atrioventricular block complete when taking Neurontin? *

  • female: 33.33 %
  • male: 66.67 %

What is the age of people who have Atrioventricular block complete when taking Neurontin? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 21.05 %
  • 60+: 78.95 %

What are other drugs people take besides Neurontin? *

  1. Plavix: 10 people, 45.45%
  2. Aldactone: 8 people, 36.36%
  3. Zocor: 5 people, 22.73%
  4. Synthroid: 5 people, 22.73%
  5. Ambien: 4 people, 18.18%
  6. Rocaltrol: 4 people, 18.18%
  7. Baraclude: 4 people, 18.18%
  8. Xanax: 4 people, 18.18%
  9. Novorapid: 4 people, 18.18%
  10. Norvasc: 4 people, 18.18%

What are other side effects people have besides Atrioventricular block complete? *

  1. Bradycardia (abnormally slow heart action): 7 people, 31.82%
  2. Nausea (feeling of having an urge to vomit): 5 people, 22.73%
  3. Ventricular Extrasystoles (premature cardiac contraction): 5 people, 22.73%
  4. Hyperkalemia (damage to or disease of the kidney): 5 people, 22.73%
  5. Dyspnea (difficult or laboured breathing): 5 people, 22.73%
  6. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 5 people, 22.73%
  7. Stress And Anxiety: 5 people, 22.73%
  8. Malaise (a feeling of general discomfort or uneasiness): 5 people, 22.73%
  9. Chest Pain: 5 people, 22.73%
  10. Headache (pain in head): 4 people, 18.18%

What are the existing conditions these people have? *

  1. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 27.27%
  2. High Blood Pressure: 5 people, 22.73%
  3. Peripheral Arterial Occlusive Disease (reproducible ischemic muscle pain): 4 people, 18.18%
  4. Hepatitis B: 4 people, 18.18%
  5. Type 2 Diabetes: 2 people, 9.09%
  6. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 2 people, 9.09%
  7. Cardiac Disorder: 2 people, 9.09%
  8. Cardiac Failure Congestive: 2 people, 9.09%
  9. Cirrhosis Alcoholic (chronic disease of the liver marked by degeneration of cells, inflammation, and fibrous thickening of tissue caused by alcoholism): 2 people, 9.09%
  10. Wound: 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Neurontin and have Atrioventricular block complete?

- Check whether Atrioventricular block complete is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Neurontin:

Atrioventricular block complete treatments and more:

How severe was Atrioventricular block complete and when was it recovered:

Expand to all the drugs that have ingredients of gabapentin:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Neurontin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Atrioventricular block complete:

Browse all the conditions that are associated with Atrioventricular block complete:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on gabapentin (the active ingredients of Neurontin) and Neurontin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.